Denosumab Medication Information

Get detailed information on Denosumab, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it.

The updated prescription information on Denosumab provides an overview of possible side effects, precautions, warnings, and storage tips.

You'll also find brand names used in india and internationally, along with pricing details. For further clarification, consult your healthcare provider.

Generic Name : Denosumab

Pronunciation : den-OH-sue-mab

ICD Code : Y43.4 Therapeutic Classification : Monoclonal antibodies

Trade Names/Brand Names of Denosumab

International :

Prolia

Why is Denosumab Prescribed? (Indications)

This medication is a human monoclonal antibody, prescribed for osteoporosis, treatment induced bone loss, bone metastases, rheumatoid arthritis, multiple myeloma and giant cell tumor of bone.

When should Denosumab not be taken? (Contraindications)

♦ Contraindicated in patients with hypocalcemia, multiple myeloma, hypersensitivity and during pregnancy.

What is the dosage of Denosumab?

SC- The recommended dose is 120 mg, for every 4 weeks in the upper arm, upper thigh, or abdomen.

How should Denosumab be taken?

It comes as a solution for injection to be administered by a healthcare provider under the skin.

What are the warnings and precautions for Denosumab?

• Caution should be exercised in patients with history of kidney impairment, anemia, low blood calcium, any allergy, who are taking other medications, thyroid or kidney disease, infection, during pregnancy and breastfeeding.

• In some patients, this medication may cause jawbone problems.

♦Patient may develop Osteonecrosis of the Jaw (ONJ) with the following symptom: gum lesions. If it is so consult with your healthcare provider immediately.